Skip to main content
. Author manuscript; available in PMC: 2017 Oct 23.
Published in final edited form as: J Neuroimmunol. 2012 Aug 4;252(1-2):33–39. doi: 10.1016/j.jneuroim.2012.07.010

Fig. 4.

Fig. 4

Effect of hIL-1RA on hippocampal macrophage/microglial activation markers. Four days post-ICM injection of either vehicle (0.9%) or hIL-1RA (100 μg), gene expression of macrophage and glial antigens was measured in the hippocampus. For each marker, hIL-1RA treatment means were significantly different (*p<.05) than their respective vehicle control. Data are presented as the mean±SEM.

HHS Vulnerability Disclosure